rs6075209

Positions:

• chr20-17434574-G-A
• chr20-17434574-G-T

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_Strong BA1

The NM_002594.5(PCSK2):​c.710-2134G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.353 in 151,992 control chromosomes in the GnomAD database, including 9,930 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency: Genomes: 𝑓 0.35 (9930 hom., cov: 31)
• Consequence: PCSK2 NM_002594.5 intron
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: 0.237

Genes affected

PCSK2 (HGNC:8744): (proprotein convertase subtilisin/kexin type 2) This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The protein undergoes an initial autocatalytic processing event and interacts with a neuroendocrine secretory protein in the ER, exits the ER and sorts to secretory granules, where it is cleaved and catalytically activated during intracellular transport. The encoded protease is packaged into and activated in dense core secretory granules and expressed in the neuroendocrine system and brain. This gene encodes one of the seven basic amino acid-specific members which cleave their substrates at single or paired basic residues. It functions in the proteolytic activation of polypeptide hormones and neuropeptides precursors. Single nucleotide polymorphisms in this gene may increase susceptibility to myocardial infarction and type 2 diabetes. This gene may also play a role in tumor development and progression. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jan 2014]

ACMG classification

Verdict is Benign. Variant got -12 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.82).
• BA1: GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.555 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	UniProt
PCSK2	NM_002594.5	c.710-2134G>A		intron_variant		ENST00000262545.7
PCSK2	NM_001201528.2	c.653-2134G>A		intron_variant
PCSK2	NM_001201529.3	c.605-2134G>A		intron_variant

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Appris	UniProt
PCSK2	ENST00000262545.7	c.710-2134G>A		intron_variant		1	NM_002594.5	P1
PCSK2	ENST00000377899.5	c.653-2134G>A		intron_variant		1
PCSK2	ENST00000536609.1	c.605-2134G>A		intron_variant		2

Frequencies

GnomAD3 genomes AF: 0.353 AC: 53568 AN: 151874 Hom.: 9930 Cov.: 31

Gnomad AFR AF: 0.255

Gnomad AMI AF: 0.411

Gnomad AMR AF: 0.299

Gnomad ASJ AF: 0.356

Gnomad EAS AF: 0.304

Gnomad SAS AF: 0.573

Gnomad FIN AF: 0.360

Gnomad MID AF: 0.367

Gnomad NFE AF: 0.409

Gnomad OTH AF: 0.385

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome AF: 0.353 AC: 53583 AN: 151992 Hom.: 9930 Cov.: 31 AF XY: 0.355 AC XY: 26367 AN XY: 74272

Gnomad4 AFR AF: 0.255

Gnomad4 AMR AF: 0.298

Gnomad4 ASJ AF: 0.356

Gnomad4 EAS AF: 0.304

Gnomad4 SAS AF: 0.572

Gnomad4 FIN AF: 0.360

Gnomad4 NFE AF: 0.409

Gnomad4 OTH AF: 0.382

Alfa AF: 0.386 Hom.: 10789

Bravo AF: 0.337

Asia WGS AF: 0.394 AC: 1370 AN: 3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.82
CADD	Benign	2.4
DANN	Benign	0.73

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs6075209; hg19: chr20-17415219;